Mortality in sleep apnoea syndrome: a review of the evidence

Lavie P.

Source: Eur Respir Rev 2007; 16: 203-210
Journal Issue: December 2007 - 17 (106)
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lavie P.. Mortality in sleep apnoea syndrome: a review of the evidence. Eur Respir Rev 2007; 16: 203-210

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005


Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2012; 39: 906-912
Year: 2012



Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002



Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006


Obstructive sleep apnoea doesn‘t increase risk of cardiovascular morbidity and mortality in patients with arterial hypertension
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008


Is there a gender difference in cardiovascular mortality in obstructive sleep apnoea?
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009

All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age
Source: Eur Respir J 2005; 25: 514-520
Year: 2005



Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Increased cardiovascular mortality in obstructive sleep apnoea: a 7-year follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 343s
Year: 2001

Morbidity and mortality in sleep apnoea across the ages
Source: ERS Conference
Year: 2015

Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients
Source: ERJ Open Res, 6 (2) 00101-2019; 10.1183/23120541.00101-2019
Year: 2020



Obstructive sleep apnea
Source: Respipedia Article
Year: 2017

Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Sleep-related breathing disorders: impact on mortality of cerebrovascular disease
Source: Eur Respir J 2004; 24: 267-272
Year: 2004



Mortality and morbidity in obstructive sleep apnoea–hypopnoea syndrome: results from a 30-year prospective cohort study
Source: ERJ Open Res, 6 (3) 00057-2020; 10.1183/23120541.00057-2020
Year: 2020



Impact of obstructive sleep apnea and CPAP treatment on mortality and cardio and cerebrovascular consequences in men of the general population after 20 years of follow-up.
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020


Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients
Source: Eur Respir J 2003 Dec 01;22(6):943-950
Year: 2003